The WTO medicines decision: world pharmaceutical trade and the protection of public health FM Abbott American Journal of International Law 99 (2), 317-358, 2005 | 484 | 2005 |
The Doha declaration on the TRIPS agreement and public health: lighting a dark corner at the WTO FM Abbott J. Int'l Econ. L. 5, 469, 2002 | 367 | 2002 |
The Doha Round's public health legacy: Strategies for the production and diffusion of patented medicines under the amended TRIPS provisions FM Abbott, JH Reichman Journal of international economic law 10 (4), 921-987, 2007 | 330 | 2007 |
Protecting first world assets in the third world: Intellectual Property negotiations in the GATT multilateral framework FM Abbott Vand. J. Transnat'l L. 22, 689, 1989 | 279 | 1989 |
NAFTA and the legalization of world politics: a case study FM Abbott International Organization 54 (3), 519-547, 2000 | 246 | 2000 |
First report (final) to the committee on international trade law of the international law association on the subject of parallel importation FM Abbott Journal of International Economic Law 1 (4), 607-636, 1998 | 193 | 1998 |
The international intellectual property system: commentary and materials F Abbott, T Cottier Wolters Kluwer, 1999 | 162 | 1999 |
The Scope of US Senate Control over the Conclusion and Operation of Treaties SA Riesenfeld, FM Abbott Chi.-Kent L. Rev. 67, 571, 1991 | 159 | 1991 |
International intellectual property in an integrated world economy FM Abbott, T Cottier, F Gurry Aspen Publishing, 2019 | 152 | 2019 |
The Trips Agreement, Access to Medicines, and the Wto Doha Ministerial Conference FM Abbott The journal of world intellectual property 5 (1), 15-52, 2002 | 109 | 2002 |
Intellectual property provisions of bilateral and regional trade agreements in light of US federal law FM Abbott UNCTAD-ICTSD Project on IPRs and Sustainable Development, Issue Paper, 2006 | 107 | 2006 |
Distributed governance at the WTO-WIPO: an evolving model for open-architecture integrated governance FM Abbott Journal of International Economic Law 3 (1), 63-81, 2000 | 105 | 2000 |
The Doha Declaration on the TRIPS Agreement and Public Health and the contradictory trend in bilateral and regional free trade agreements FM Abbott Quaker United Nations Office (Geneva)(QUNO), Occasional Paper, 2004 | 95 | 2004 |
Integration without Institutions: The NAFTA Mutation of the EC Model and the Future of the GATT Regime FM Abbott The American Journal of Comparative Law 40 (4), 917-949, 1992 | 92 | 1992 |
TRIPS in Seattle: the not-so-surprising failure and the future of the TRIPS agenda FM Abbott Berkeley J. Int'l L. 18, 165, 2000 | 83 | 2000 |
The enduring enigma of TRIPS: A challenge for the world economic system FM Abbott Journal of International Economic Law 1 (4), 497-521, 1998 | 80 | 1998 |
A new dominant trade species emerges: is bilateralism a threat? FM Abbott Journal of International Economic Law 10 (3), 571-583, 2007 | 76 | 2007 |
Facilitating access to Cross-border supplies of patented pharmaceuticals: the case of the COVID-19 pandemic FM Abbott, JH Reichman Journal of International Economic Law 23 (3), 535-561, 2020 | 69 | 2020 |
Excessive pharmaceutical prices and competition law: doctrinal development to protect public health FM Abbott UC Irvine L. Rev. 6, 281, 2016 | 67 | 2016 |
Compulsory licensing for public health needs: the TRIPS agenda at the WTO after the Doha declaration on public health FM Abbott Occasional Paper 9, 2002 | 66 | 2002 |